IFI-K · Propionamide Analog

Specimen SS-F-KOK-955 // KOKUMI · IFI-K

Propionamide Analog V-BL-A

Saccharomyces cerevisiae

Yeast

Tier VPropionamide Analog

Target Trait

2.8×

fold-change

Glutathione-analog amide CaSR kokumi fold-change in Saccharomyces cerevisiae

Technical Specifications

SKU

SS-F-KOK-955

Genomic Edits

6

GC Content

43.6%

Construct Length

3,670 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic particle delivery

Host Strain

0.6µm Gold Particle

Receptor Target

CaSR (calcium-sensing receptor)

IFI Score

280

Pathway Edits

  • BAHD-AT (BAHD acyltransferase) expression for propionyl group transfer to GSH scaffold
  • GCL substrate supply for γ-glutamyl-cysteinyl scaffold production as BAHD-AT acceptor
  • GS-alt (alternative glutathione synthetase) expression for amide bond formation on analog scaffold
  • AAT (amino acid acetyltransferase) expression for amide bond optimization in analog structure
  • Amide-GSH analog permease expression for cytosolic accumulation of CaSR-active analog

Key Interventions

BAHD-AT acyltransferase expression for propionamide-GSH analog biosynthesis as CaSR kokumi ligandGCL/GS-alt γ-glutamyl-cysteinyl scaffold supply for BAHD-AT-catalyzed acyl modificationAAT amide bond formation optimization for structurally constrained CaSR analog engagementBiolistic particle delivery delivery optimized for Saccharomyces cerevisiae genome accessibilityTier-V construct validated with 6 precision edits for 2.8× fold-change

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
280
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Ultra-premium propionamide-GSH CaSR analog for luxury specialty fermentation product lines

License

$9999 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Kokumi · IFI-KAll Modalities